Bozeman, MT (January, 16, 2008) – Golden Helix, Inc., the global leader in genetic association software, today announced it has launched a collaboration program to refine and advance the science of copy number analysis and further the research of its collaborating partners. Inaugural collaborators include University of California Los Angeles, The Zucker Hillside Hospital, Montreal Heart Institute, Emory University, Case Western Reserve University and University at Lübeck (Germany). Several additional collaborations are expected to be announced in the coming months.
Golden Helix introduced the opportunity for collaboration to more than 200 attendees during a webcast last month in which it highlighted its newest analysis package, CNAM, which incorporates novel methods for whole genome copy number association studies. The webcast prompted 20 institutions to submit proposals.
“We were surprised with the quantity of proposals we received, but copy number analysis is an exciting and challenging area of research,” stated Josh Forsythe, Director of Marketing at Golden Helix. “The response illustrates the large demand for better approaches to handling and analyzing copy number data.”
According to Dr. Christophe Lambert, President and CEO of Golden Helix, the collaborations are mutually beneficial. “These collaborations represent a great opportunity to combine Golden Helix’s expertise in informatics and statistics with our collaborators’ in-depth knowledge about the biology of their diseases under study. Joining forces will help us refine our methods and software and ensure they are used optimally for real-world research, while furthering the studies of our collaborators and advancing the copy number analysis field. Our goal is to help our collaborators be among the first to publish significant whole genome copy number association findings.”
Altogether, the collaborations cover a diverse set of diseases and sample characteristics as well as data generated from multiple Illumina and Affymetrix genotyping platforms. According to the agreement, Golden Helix will help perform data conversion, quality control, and data analysis in exchange for the purchase of its software and feedback that will help improve its analysis products.
About Golden Helix
Founded in 1998, Golden Helix has become the global leader in SNP analysis and genetic association software. The company's products are used by hundreds of researchers at the world's top pharmaceutical, biotech and non-profit research organizations, and have been cited in over 100 peer reviewed publications that detail ground-breaking research uncovering the genetic and environmental basis of disease. Golden Helix is committed to Accelerating the Quest for Significance. For more information, please visit www.goldenhelix.com.
Director of Marketing
Golden Helix, Inc.